For Healthcare Professionals: Myelodysplastic Syndrome

We provide comprehensive care to more than 100 individuals newly diagnosed with myelodysplastic syndromes annually. In addition to our designation as a Center of Excellence by the Myelodysplastic Syndromes Foundation, we are recognized as a leading institution for stem cell transplantation for MDS. We direct numerous clinical trials of investigational agents and innovative treatment approaches.

Refering a Patient

Call 866-218-8132
Mon–Fri, 8:30 AM–5:30 PM, ET

Find an Expert | See Clinical Trials | Request a Pathology Consult

More Science. Less Fear.
It’s Time to Change How the World Treats Cancer.

Learn how we’re making what was impossible yesterday, possible today.

Pictured: Peter Maslak
Myelodysplatic Syndrome Information for Your Patients

The Memorial Sloan Kettering approach to diagnosis and treatment of myelodysplatic syndrome in patient-friendly language.

E-Publications for Medical Professionals

Stay up-to-date on Memorial Sloan Kettering advances in your areas of interest.

Subscribe to OncoNotes »

Pictured: Virginia Klimek
Phase III Trial for Patients with Myelodysplastic Syndromes and Symptomatic Anemia

Medical oncologist Virginia Klimek discusses a multicenter Phase III randomized clinical trial for MDS patients with symptomatic anemia.